We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-1.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$278M
AUM Growth
+$52.8M
(+23%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
20.7%
Top 10 Holdings %
Top 10 Hldgs %
61.69%
Holding
40
New
13
Increased
9
Reduced
4
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APOL
Apollo Education Group Inc Class A
APOL
|
+$14.7M |
| 2 |
FTD
FTD Companies, Inc. Common Stock
FTD
|
+$13.2M |
| 3 |
SKUL
SKULLCANDY INC
SKUL
|
+$12.8M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
+$11M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanda Pharmaceuticals
VNDA
|
+$12.3M |
| 2 |
RXDX
Ignyta, Inc.
RXDX
|
+$11M |
| 3 |
PBY
PEP BOYS MANNY MOE& JACK
PBY
|
+$10.5M |
| 4 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
+$8.99M |
| 5 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.82% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 8.32% |
| 4 | Financials | 4.06% |
| 5 | Technology | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $30.9M | 11.09% |
150,000
| – | – |
|
|
SPPI
2
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $30.3M | 10.9% |
4,436,000
+1,736,000
| +64% | +$11M |
|
|
APOL
3
DELISTED
Apollo Education Group Inc Class A
APOL
| $16.4M | 5.88% |
1,270,000
+870,000
| +218% | +$14.7M |
|
4
Kodak
KODK
$806M
| $16.1M | 5.79% |
960,000
+360,000
| +60% | +$6.84M |
|
|
5
Vanda Pharmaceuticals
VNDA
$312M
| $14.5M | 5.21% |
1,142,000
-1,142,000
| -50% | -$12.3M |
|
|
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
| $13.3M | 4.78% |
6,400,000
+2,600,000
| +68% | +$6.3M |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $13.1M | 4.72% |
870,000
-910,000
| -51% | -$11M |
|
|
FTD
8
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $12.9M | 4.64% |
+458,000
| New | +$13.2M |
|
9
Theravance Biopharma
TBPH
$874M
| $12.7M | 4.56% |
974,000
+462,000
| +90% | +$7.17M |
|
|
QLGC
10
DELISTED
QLOGIC CORP
QLGC
| $11.5M | 4.14% |
812,000
+344,000
| +74% | +$5.17M |
|
|
AVTA
11
DELISTED
Avantax, Inc. Common Stock
AVTA
| $11.3M | 4.06% |
700,000
-74,000
| -10% | -$1.14M |
|
|
SKUL
12
DELISTED
SKULLCANDY INC
SKUL
| $10.8M | 3.87% |
+1,406,000
| New | +$12.8M |
|
|
BBBY
13
Bed Bath & Beyond
BBBY
$473M
| $10.1M | 3.61% |
593,626
+499,125
| +528% | +$8.48M |
|
|
XNPT
14
DELISTED
XENOPORT, INC.
XNPT
| $9.81M | 3.52% |
+1,600,000
| New | +$10.5M |
|
15
Abercrombie & Fitch
ANF
$4.17B
| $8.86M | 3.18% |
+412,000
| New | +$9.07M |
|
|
TVTY
16
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.67M | 2.75% |
+640,000
| New | +$10.6M |
|
17
Lipocine
LPCN
$17.1M
| $7.29M | 2.62% |
+50,000
| New | +$6.21M |
|
|
SNAK
18
DELISTED
Inventure Foods, Inc.
SNAK
| $6.27M | 2.25% |
618,000
+18,000
| +3% | +$184K |
|
|
ACOR
19
DELISTED
Acorda Therapeutics
ACOR
| $6.2M | 2.23% |
+1,550
| New | +$5.99M |
|
|
LEAF
20
DELISTED
Leaf Group Ltd.
LEAF
| $6.16M | 2.21% |
968,000
+52,000
| +6% | +$308K |
|
|
STKL
21
DELISTED
SunOpta
STKL
| $4.55M | 1.63% |
+424,000
| New | +$4.48M |
|
|
JCP
22
DELISTED
J.C. Penney Company, Inc.
JCP
| $4.24M | 1.52% |
+500,000
| New | +$4.31M |
|
|
BITI
23
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| $3.99M | 1.43% |
+200,000
| New | +$4.17M |
|
|
BDSI
24
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.18M | 1.14% |
+400,000
| New | +$3.44M |
|
|
QLTI
25
DELISTED
QLT Inc
QLTI
| $2.73M | 0.98% |
+660,000
| New | +$2.53M |
|
Similar funds
CRC
RMDI
F
DWM
DCP
EW
AIM
O
Armistice Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Armistice Capital held 40 positions worth $278M, up 23% from $226M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Armistice Capital deployed $57.6M of net new capital in Q2 2015, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was FTD Companies, Inc. Common Stock: 458,000 shares worth $12.9M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 46% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vanda Pharmaceuticals, an estimated $12.3M trimmed.
- Armistice Capital's largest Q2 2015 buy was FTD Companies, Inc. Common Stock: 458,000 shares worth $12.9M.
- Armistice Capital added most to Apollo Education Group Inc Class A in Q2 2015, an estimated $14.7M increase.
- Armistice Capital's biggest Q2 2015 reduction was Vanda Pharmaceuticals, cutting an estimated $12.3M.
- Armistice Capital fully exited PEP BOYS MANNY MOE& JACK in Q2 2015, selling an estimated $10.5M.
- Armistice Capital's ten largest holdings make up 62% of its $278M portfolio in Q2 2015.
- Armistice Capital opened 13 new positions and closed 12 in Q2 2015.
- Armistice Capital's portfolio value rose 23% quarter-over-quarter to $278M.
Based on Armistice Capital's 13F filing for Q2 2015, filed 14 Aug 2015.